Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
47 /100
MEDIUM RISK
Score updated Oct 13, 2026

OBIO — Orchestra BioMed Holdings, Inc. Dilution Risk Tracker

Track OBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OBIO — Get alerts when the score changes →

As of October 13, 2026, Orchestra BioMed Holdings, Inc. (OBIO) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Orchestra BioMed Holdings, Inc. has a market capitalization of $355.22M, 60.11M shares outstanding, 66 institutional holders tracked. Stored dilution-related fields include 8.03M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
25
📊 Float Risk
50
⚠️ Warrant Exposure
50
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 12%
📜 Warrant Exercise model 15%
• Warrant overhang: 13.4% of shares outstanding
🔁 Convertible Conversion model 15%
• Convertible debt present: 5.8% potential dilution
🔔 Track OBIO — Get forecast alerts →

Market Data

Market Cap$355.22M
Shares Outstanding60.11M
Float33.55M
Cash$109.96M
Debt$15.00M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore47/100DilutionWatch score record
Shares Outstanding60.11MVerified float table or market cache
Public Float33.55MVerified float table or market cache
Market Cap$355.22MMarket data cache
Cash Runway19.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants8.03MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 39.7% shares (2026Q1 vs prior)
66 institutional holders · 30.76M shares
#1 PERCEPTIVE ADVISORS LLC 10.08M shares
#2 RTW INVESTMENTS, LP 8.31M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.41M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.55M
Days to Cover7.0
% of Float7.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-10
xbrl XBRL CONVERTIBLE 2026-08-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual OBIO Dilution Snapshot

Orchestra BioMed Holdings, Inc. (OBIO) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

OBIO's DilutionScore is currently 47/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 45/100 (Medium risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202647/100MEDIUM16 days
Aug 22 – Sep 27, 202645/100MEDIUM37 days
Aug 14 – Aug 21, 202650/100MEDIUM7 days
Jul 16 – Aug 13, 202661/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

OBIO shares outstanding have increased 6.0% from 56.46M (Mar 2026) to 59.88M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 202659.88M33.55M▲ 2.32%
May 11, 202659.88M32.79M▲ 1.86%
May 02, 202658.52M32.20M▼ 0.90%
Apr 18, 202658.52M32.49M▲ 0.16%
Apr 17, 202658.52M32.44M▼ 0.16%
Mar 30, 202658.52M32.44M▼ 0.03%
Mar 17, 202656.46M32.44M▲ 13.67%
Mar 13, 202656.46M28.54M▲ 3.64%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track OBIO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment OBIO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking OBIO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OBIO
OBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.